DIAGNOSTIC TESTING PROGRAMS

Travere sponsors diagnostic testing at no cost to qualified patients to help accurately identify a variety of conditions.

On September 5, 2023, Travere Therapeutics announced that Mirum Pharmaceuticals acquired all of Travere’s rights and assets related to Cholbam® and Chenodal®. For more information please visit mirumpharma.com.